The Koch Institute for Integrative Cancer Research at MIT

an accordion of endothelial cells stained in pink and green

Using MIT ingenuity to create knowledge, tools, and treatments to fight cancer

Join us 

Our Research Areas

From fundamental discoveries to engineering advances, we strategically pursue five areas of research that, across tumor types, are critical for rapid progress toward defeating cancer.

As a National Cancer Institute-designated basic cancer research center, we produce knowledge and tools to fight one of humanity's most persistent challenges.

NCI Cancer Center: A Cancer Center Designated by the National Cancer Institute
Detection & monitoring  
Metastasis  
Immunology & immunotherapy  
Nano-based drugs  
Precision medicine  

News

Introducing the 2024 Karches Prize winners

January 24, 2025

Congratulations to the winners of the 2024 Peter Karches Mentorship Prize — Shandon Amos, Christina Cabana, Ivan Pires, and Jason Yu.

The Peter Karches Mentorship Prize is awarded annually to up to four Koch Institute postdocs, graduate students or research technicians who demonstrate exemplary mentorship of undergraduate researchers or high school students in their labs. The prize allows the Koch Institute community to celebrate and recognize the critical role that mentors play, both personally and professionally, in the early stages of a scientist’s career.

Cima bladder device reaches FDA application

MIT Department of Materials Science and Engineering

Johnson & Johnson has submitted a new drug application to the FDA for an implantable device developed by the Cima lab to make treating bladder cancer safer, more effective and less costly.

Angela Belcher and Paula Hammond win 2024 National Medals of Science, Technology

MIT News

Congratulations to MIT's latest National Medals of Science and Technology laureates, including the Koch Institute's own Angela Belcher and Paula Hammond.

More News 

At the Koch Institute for Integrative Cancer Research, scientists and engineers work together to solve some of the most difficult problems in cancer. We ask big questions in strategic areas, where the answers have big impacts on how we understand and treat cancer.